Hormone Receptor-Positive Localized Breast Cancer — A Grand Rounds Activity

Oncology Today with Dr Neil Love · Oct 29, 2026 · 1h

Featuring an interview with Dr Erica Mayer, including the following topics:

Risk Assessment and Genomic Assays for Hormone Receptor (HR)-Positive, HER2-Negative Localized Breast Cancer (0:00)

Investigator Survey Results on Risk Assessment and Genomic Assays (20:07)

Adjuvant CDK4/6 Inhibitors for High-Risk, HR-Positive, HER2-Negative Localized Breast Cancer (24:30)

Investigator Survey Results on Adjuvant CDK4/6 Inhibitors (30:42)

Tolerability and Other Practical Considerations with Adjuvant CDK4/6 Inhibitor Therapy (32:07)

Investigator Survey Results on Tolerability and Other Practical…